Word: secondings
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Princess and the Frog, $12.2 million; $44.8 million, fourth week 3. The Blind Side, $10 million; $164.7 million, fifth week 4. Did You Hear About the Morgans, $7 million, first weekend 5. The Twilight Saga: New Moon, $4.4 million; $274.6 million, fifth week 6. Invictus, $4.1 million; $15.8 million, second week 7. Disney's A Christmas Carol, $3.4 million; $130.8 million, seventh week 8. Up in the Air, $3.1 million; $8.1 million, third week 9. Brothers, $2.6 million; $22.1 million third week 10. Old Dogs, $2.3 million; $43.6 million, fourth week...
...Wait a second. Will the stock market go up or down? That major discrepancy raises an important point. Making predictions a year out is a tricky - and unreliable - business...
...better than responses to seasonal flu vaccines of past years," says Terry Nolan of the University of Melbourne, the lead author of the study. That's good news for parents and public health officials, particularly in light of the fact that about half of U.S. children never get their second dose of seasonal flu vaccine. (See how not to get the H1N1...
...involved 370 healthy children ages six months to nine years in Australia, researchers immunized half of the group with two doses of vaccine, each containing 15 micrograms (mcg) of the virus antigen. The other half received two doses containing 30 mcg of the antigen each. In both cases, the second dose was given 21 days after the first. The researchers found that 21 days after receiving only one shot, 92.5% of children in the 15-mcg-dose group and 98% of those receiving the higher dose had generated sufficient antibodies against H1N1...
...until then, neither Nolan nor officials at the Centers for Disease Control and Prevention (CDC) are ready to ditch the second dose. For one thing, they note, the level of antibodies does not always translate to actual protection against the flu. "Lab studies are a proxy and work well," says Dr. Anthony Fiore, at the CDC's National Center for Infectious Diseases, who wrote an editorial accompanying the study in the Journal of the American Medical Association. "But until you can show that a single dose is as effective as two, it's probably too soon to pull away from...